Successful allogeneic transplantation of patients with suspected prior invasive mold infection

Leukemia and Lymphoma

Volumn 48, Issue 9, 2007, Pages 1799-1805

  Hill, Brian T ^a   Kondapalli, Lavayna ^a   Artz, Andrew ^a   Smith, Sonali ^a   Rich, Elizabeth ^a   Godley, Lucy ^a   Odenike, Olatoyosi ^a   Pursell, Kenneth J ^a   Larson, Richard A ^a   Stock, Wendy ^a   van Besien, Koen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphotericin; Aspergillus; Bone marrow transplantation; Caspofungin; Fungal pneumonia; Voriconazole

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; FLUDARABINE; ITRACONAZOLE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VORICONAZOLE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS FUMIGATUS; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ENGRAFTMENT; ENZYME IMMUNOASSAY; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; LUNG BIOPSY; LUNG INFECTION; LUNG LAVAGE; MALE; MYCOSIS; MYELOABLATIVE CONDITIONING; NEPHROTOXICITY; PRIORITY JOURNAL; RECURRENT INFECTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGED; ANTIFUNGAL AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYCOSES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548546786     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701534390     Document Type: Article

References (28)

1. Offner, F., Cordonnier, C., Ljungman, P., Prentice, H. G., Engelhard, D. and De Bacquer, D. (1998) Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infec Dis, 26, pp. 1098-1103.
2. Hovi, L., Saarinen-Pihkala, U. M., Vettenranta, K. and Saxen, H. (2000) Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years. Bone Marrow Transplant, 26, pp. 999-1004.
3. Pannuti, C. S., Gingrich, R. D., Pfaller, M. A. and Wenzel, R. P. (1991) Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: A 9-year study. J Clin Oncol, 9, pp. 77-84.
4. Schwartz, R. S., Mackintosh, F. R., Schrier, S. L. and Greenberg, P. L. (1984) Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer, 53, pp. 411-419.
5. Denning, D. W. and Stevens, D. A. (1990) Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases. Rev Infect Dis, 12, pp. 1147-1201.
6. De Bock, R. (1994) Epidemiology of invasive fungal infections in bone marrow transplantation. EORTC Invasive Fungal Infections Cooperative Group. Bone Marrow Transplant, 14, pp. S1-S2.
7. McWhinney, P. H., Kibbler, C. C., Hamon, M. D., Smith, O. P., Gandhi, L. and Berger, L. A. (1993) Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis, 17:3, pp. 397-404.
8. Wade, J. C. (1997) Treatment of fungal and other opportunistic infections in immunocompromised patients (review). Leukemia, 11, pp. S38-S39.
9. Noskin, G., Pietrelli, L., Gurwith, M. and Bowden, R. (1999) Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients (review). Bone Marrow Transplant, 23, pp. 697-703.
10. Cordonnier, C., Maury, S., Pautas, C., Basté, J. N., Chehata, S. and Castaigne, S. (2004) Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transplant, 33, pp. 943-948.
11. Wingard, J. R. and Leather, H. (2004) A new era of antifungal therapy. Biol Blood Marrow Transplant, 10, pp. 73-90.
12. Verma, A., Williams, S., Trifilio, S., Zembower, T. and Mehta, J. (2004) Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplant, 33, pp. 1065-1066.
13. Mattei, D., Mordini, N., Nigro, C Lo, Ghirardo, D., Ferrua, M. T. and Osenda, M. (2002) Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. Bone Marrow Transplant, 30, pp. 967-970.
14. Ifran, A., Kaptan, K. and Beyan, C. (2005) Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation. Mycoses, 48, pp. 146-148.
15. Martino, R., Parody, R., Fukuda, T., Maertens, J. and Theunissen, K. (2006) Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood, 108, pp. 2928-2936.
16. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J. and Crokaert, F. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis, 34, pp. 7-14.
17. Robertson, M. and Larson, R. A. (1988) Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med, 84, pp. 233-239.
18. Krüger, W. H., Rüssmann, B., de Wit, M., Kröger, N., Renges, H. and Sobottka, I. (2005) Haemopoeitic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B. Acta Haematol, 113, pp. 104-108.
19. Fukuda, T., Boeckh, M., Guthrie, K. A., Mattson, D. K., Owens, S. and Wald, A. (2004) Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant, 10, pp. 494-503.
20. van Besien, K., Artz, A., Smith, S., Cao, D., Rich, S. and Godley, L. (2005) Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol, 23, pp. 5728-5738.
21. Richard, C., Romón, I., Baro, J., Insunza, A., Loyola, I. and Zurbano, F. (1993) Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant, 12, pp. 237-241.
22. Michailov, G., Laporte, J. P., Lesage, S., Fouillard, L., Isnard, F. and Noel-Walter, M. P. (1996) Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis. Bone Marrow Transplant, 17, pp. 569-572.
23. Fukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B. and Maloney, D. G. (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood, 102, pp. 827-833.
24. Avivi, I., Oren, I., Haddad, N., Rowe, J. and Dann, E. (2004) Stem cell transplantation post invasive fungal infection is a feasible task. Am J of Hematol, 75, pp. 6-11.
25. Martino, R., Nomdedéu, J., Altés, A., Sureda, A., Brunet, S. and Martínez, C. (1994) Successful bone marrow transplantation in patients with previous invasive fungal infections: Report of four cases. Bone Marrow Transplant, 13, pp. 265-269.
26. Hoover, M., Morgan, E. R. and Kletzel, M. (1997) Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediatr Oncol, 28, pp. 268-273.
27. Wang, J. T., Yao, M., Tang, J. L., Chang, S. C. and Hung, C. C. (2001) Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies. J Clin Oncol, 19, pp. 4000-4001.
28. Sipsas, N. V. and Kontoyiannis, D. P. (2006) Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis, 42, pp. 1584-1591.